The circulating cell-free tumor DNA market involves products and tools utilized for isolating and analyzing circulating tumor DNA fragments present in blood or other body fluids. Circulating cell-free tumor DNA serves as a non-invasive alternative to tissue biopsies and provides important insights into somatic mutations present in tumors. They aid doctors in monitoring treatment response, detecting recurrence, and better understanding the genetic underpinnings of disease. The demand for ... Read more
Circulating cell-free tumor DNA (ctDNA) refers to fragments of tumor DNA that circulate in the bloodstream outside of cells. When cancer cells die, they release fragments of their DNA into the bloodstream. This DNA circulates in small fragments known as ctDNA. Detecting and analyzing ctDNA can provide important information about the characteristics and evolution of a patient's tumor.
